Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer’s disease - Medco PRF

CALL NOW: (708) 237-3750

Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer’s disease

SCT_Alzheimer_Administrations-of-human-adult-ischemia-tolerant-mesenchymal

By Medco PRF|2022-01-15T04:56:22-06:00October 26th, 2021|Articles|0 Comments

Leave A Comment Cancel reply